Some people are facing delays in filling prescriptions for the glucose sensor. Abbott expects to resolve the problem soon.

DexCom's revised FY24 sales guidance in the Q2 earnings call led to a $18bn valuation reset. Read why I think DXCM stock is a ...

ABT made its CGM system Lingo available in the United States. The system can be used by consumers aged 18 years and older who ...

Lingo is based on Abbott's FreeStyle Libre CGM technology. It can be used by consumers aged 18 years and older who are not on insulin. The system is worn on the back of the arm for up to 14 days.

Compared with eating over 14+ hours per day, eating only within an 8-hour window over 3 days significantly increased time ...

Abbott (NYSE: ABT) today announced U.S. availability of Lingo™, the company's first continuous glucose monitoring system available without a prescription. The Lingo system includes a biosensor and a ...

RHHBY's Accu-Chek Smartguide will provide several predictive features aimed at enhancing patient safety. However, the device ...

MADRID — A daily 8-hour eating window controls blood glucose whether followed early or late in the day by people at ... Continuous glucose monitoring (FreeStyle Libre 2, Abbott Laboratories ...

Roche will roll out its Accu-Chek Smartguide in the Netherlands, Switzerland and Germany. The company hopes to stand out from competitors with features to predict hypoglycemia.

Eversense 365 cleared in the U.S. as an integrated continuous glucose monitoring (iCGM) system for people with diabetes With a single sensor, the Eversense 365 system provides one year of use, versus ...